Olivier Benichou

Olivier Benichou

Eli Lilly and Company - Indianapolis / United States
Others
AD Scientific Index ID: 4388618
-
person_outline Olivier Benichou's MOST POPULAR ARTICLES
1-) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone densityL Van Wesenbeeck, E Cleiren, J Gram, RK Beals, O Bénichou, ...The American Journal of Human Genetics 72 (3), 763-771, 20036142003
2-) Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel geneE Cleiren, O Bénichou, E Van Hul, J Gram, J Bollerslev, FR Singer, ...Human molecular genetics 10 (25), 2861-2867, 20014132001
3-) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trialC Becker, SR Lord, SA Studenski, SJ Warden, RA Fielding, CP Recknor, ...The lancet Diabetes & endocrinology 3 (12), 948-957, 20152812015
4-) Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patientsOD Benichou, JD Laredo, MC De VernejoulBone 26 (1), 87-93, 20002962000
5-) A phase II randomized study of subcutaneous ixekizumab, an anti–interleukin‐17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an …MC Genovese, M Greenwald, CS Cho, A Berman, L Jin, GS Cameron, ...Arthritis & rheumatology 66 (7), 1693-1704, 20142212014